Taymaa May

1.8k total citations
94 papers, 1.1k citations indexed

About

Taymaa May is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Taymaa May has authored 94 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Reproductive Medicine, 38 papers in Obstetrics and Gynecology and 34 papers in Surgery. Recurrent topics in Taymaa May's work include Ovarian cancer diagnosis and treatment (67 papers), Endometrial and Cervical Cancer Treatments (37 papers) and Intraperitoneal and Appendiceal Malignancies (30 papers). Taymaa May is often cited by papers focused on Ovarian cancer diagnosis and treatment (67 papers), Endometrial and Cervical Cancer Treatments (37 papers) and Intraperitoneal and Appendiceal Malignancies (30 papers). Taymaa May collaborates with scholars based in Canada, United States and United Kingdom. Taymaa May's co-authors include Stéphane Laframboise, Marcus Q. Bernardini, Barry P. Rosen, Ross S. Berkowitz, Donald P. Goldstein, Sarah E. Ferguson, Geneviève Bouchard‐Fortier, Lilian T. Gien, Liat Hogen and Danielle Vicus and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Lancet Oncology.

In The Last Decade

Taymaa May

86 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taymaa May Canada	17	662	457	317	259	131	94	1.1k
C. Sessa Switzerland	9	589 0.9×	593 1.3×	233 0.7×	283 1.1×	165 1.3×	18	1.2k
Enrico Breda Italy	16	730 1.1×	363 0.8×	370 1.2×	273 1.1×	49 0.4×	39	996
Karin Shih United States	18	561 0.8×	546 1.2×	307 1.0×	204 0.8×	128 1.0×	30	1.0k
Masamichi Hiura Japan	16	705 1.1×	750 1.6×	251 0.8×	198 0.8×	153 1.2×	50	1.2k
Mario Valenzano Menada Italy	19	492 0.7×	431 0.9×	225 0.7×	222 0.9×	53 0.4×	45	883
Jacob Korach Israel	24	886 1.3×	565 1.2×	222 0.7×	567 2.2×	110 0.8×	107	1.6k
Ram Eitan Israel	16	382 0.6×	276 0.6×	236 0.7×	133 0.5×	89 0.7×	73	805
Dongyan Cao China	23	898 1.4×	806 1.8×	336 1.1×	338 1.3×	196 1.5×	129	1.7k
R. Fauvet France	20	1.1k 1.6×	555 1.2×	332 1.0×	161 0.6×	60 0.5×	70	1.4k
Sara Imboden Switzerland	20	762 1.2×	955 2.1×	243 0.8×	106 0.4×	256 2.0×	90	1.3k

Countries citing papers authored by Taymaa May

Since Specialization

Citations

This map shows the geographic impact of Taymaa May's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taymaa May with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taymaa May more than expected).

Fields of papers citing papers by Taymaa May

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taymaa May. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taymaa May. The network helps show where Taymaa May may publish in the future.

Co-authorship network of co-authors of Taymaa May

This figure shows the co-authorship network connecting the top 25 collaborators of Taymaa May. A scholar is included among the top collaborators of Taymaa May based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taymaa May. Taymaa May is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feltmate, Colleen M., Jessica D. St. Laurent, Taymaa May, et al.. (2025). Trends in sentinel lymph node evaluation for vulvar melanoma in the United States from 2012 to 2018. Gynecologic Oncology. 196. 175–181.

Lheureux, Stéphanie, Taymaa May, Michelle Wilson, et al.. (2024). Phase II randomized multi-centre study of neoadjuvant olaparib in patients with platinum sensitive relapsed high grade serous ovarian cancer: The NEO trial.. Journal of Clinical Oncology. 42(16_suppl). 5506–5506. 1 indexed citations

Kim, Soyoun Rachel, et al.. (2024). Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis. International Journal of Gynecological Cancer. 34(6). 879–885. 3 indexed citations

Khan, Shahbaz, et al.. (2024). Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma. Journal of Proteome Research. 23(2). 749–759. 4 indexed citations

Feigenberg, Tomer, et al.. (2023). Bevacizumab Treatment for Low-Grade Serous Ovarian Cancer: A Systematic Review. Current Oncology. 30(9). 8159–8171. 8 indexed citations

Zhu, Jie Wei, Agata Szymiczek, Shiyu Zhang, et al.. (2023). Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. International Journal of Molecular Sciences. 24(18). 14388–14388. 16 indexed citations

Mitric, Cristina, Soyoun Rachel Kim, Gregg Nelson, et al.. (2022). EP384/#926 Cost-analysis of an enhanced recovery program after minimally invasive gynecologic oncology surgery. A210.1–A210.

May, Taymaa, et al.. (2021). Assessment of anastomotic perfusion using indocyanine green fluorescence angiography following bowel resection for gynecologic malignancies: an instructional surgical video. International Journal of Gynecological Cancer. 31(6). 932–933. 1 indexed citations

Hirte, Hal W., et al.. (2021). Neoadjuvant and adjuvant systemic therapy for newly diagnosed stage II- IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review. Critical Reviews in Oncology/Hematology. 162. 103324–103324. 9 indexed citations

10.

Hirte, Hal W., Xiaomei Yao, Sarah E. Ferguson, Taymaa May, & Laurie Elit. (2021). Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma: A systematic review. Critical Reviews in Oncology/Hematology. 162. 103336–103336. 3 indexed citations

11.

Clark, Mitchell, Alexandra Kollara, Theodore Brown, & Taymaa May. (2021). A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin. Journal of Ovarian Research. 14(1). 157–157. 2 indexed citations

12.

Kim, Soyoun Rachel, Lilian T. Gien, Allan Covens, et al.. (2020). Survival after minimally invasive surgery in early cervical cancer: is the intra-uterine manipulator to blame?. International Journal of Gynecological Cancer. 30(12). 1864–1870. 26 indexed citations

13.

Nica, Andra, Jennifer J. Lee, Nicole Look Hong, & Taymaa May. (2020). Cost-effectiveness of maintenance hormonal therapy in patients with advanced low grade serous ovarian cancer. Gynecologic Oncology. 160(1). 206–213. 3 indexed citations

14.

Bouchard‐Fortier, Geneviève, Maria C. Cusimano, Rouhi Fazelzad, et al.. (2020). Oncologic outcomes and morbidity following heated intraperitoneal chemotherapy at cytoreductive surgery for primary epithelial ovarian cancer: A systematic review and meta-analysis. Gynecologic Oncology. 158(1). 218–228. 9 indexed citations

15.

May, Taymaa, Lisa Allen, Liat Hogen, et al.. (2018). Laparoscopic Radical Trachelectomy for Embryonal Rhabdomyosarcoma of the Cervix in a 2-Year-Old Girl. Obstetrics and Gynecology. 132(6). 1486–1490. 7 indexed citations

16.

Lee, Yoo-Young, et al.. (2018). The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer. Hormones and Cancer. 9(2). 95–107. 7 indexed citations

17.

May, Taymaa, Ping Sun, Joanne Kotsopoulos, et al.. (2017). A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. International Journal of Gynecological Cancer. 27(4). 668–674. 38 indexed citations

18.

Stewart, Jocelyn M., Alicia Tone, Haiyan Jiang, et al.. (2016). The optimal time for surgery in women with serous ovarian cancer. Canadian Journal of Surgery. 59(4). 223–232. 13 indexed citations

19.

Quick, Charles M., Taymaa May, Neil S. Horowitz, & Marisa R. Nucci. (2012). Low-grade, Low-stage Endometrioid Endometrial Adenocarcinoma. International Journal of Gynecological Pathology. 31(4). 337–343. 46 indexed citations

20.

Bernardini, Marcus Q., Taymaa May, Mahmoud A. Khalifa, et al.. (2009). Evaluation of Two Management Strategies for Preoperative Grade 1 Endometrial Cancer. Obstetrics and Gynecology. 114(1). 7–15. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact